Tastein Spółka z Ograniczoną Odpowiedzialnością (KRS 0000851697, NIP 6751731954) is a Polish company, headquartered in Kraków, Małopolskie voivodeship. TASTEIN operates in: Manufacture of medical and dental instruments and supplies (PKD 32.50.Z). Industry: Other manufacturing. The company has been listed in the National Court Register since July 23, 2020.
Historical suspension of activities
Suspension: February 24, 2022 - resumed: June 2, 2025
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Tastein
Identity
- Name
- Tastein Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- July 23, 2020
- Registry status as of
- November 21, 2025
- Latest entry
- June 2, 2025
- Founding act
- 22.07.2020 R.
Articles of association history (1)
- July 22, 2020: 22.07.2020 R.
Activities
Other activities
Address and contact
- Address
- UL. GRZEGÓRZECKA, 67D, 26, 31-559, KRAKÓW, POLSKA
- Voivodeship
- MAŁOPOLSKIE
- District
- KRAKÓW
- BIURO@TASTEIN.PL
- Website
- HTTPS://TASTEIN.PL
- E-delivery address
- Not disclosed in the registry
Operational status - Tastein
Founded
July 23, 2020
5 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
KRAKÓW
MAŁOPOLSKIE
Primary PKD
32.50.Z
Manufacture of medical and dental instruments and supplies
Share capital
5.0 K PLN
88 shares total
Shareholders
1
shareholder
Board
N/A
Filed years
N/A
Registry entries
11
latest: June 2, 2025
No KPI data - financial statements and valuation are unavailable for this company.
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Tastein.
No ratings
Related articles
News
Mennica Polska 2026: Q1 revenue +80% YoY (PLN 726.7 m), 838 kg of investment gold (+38%), Bulwary Praskie 95% sold, PLN 1.5 per share dividend
Warsaw-based Mennica Polska S.A. (KRS 0000019196), the only Polish producer of investment-gold bars with three independent business legs (minting, the City Card transit ticket, and the Bulwary Praskie real-estate developer), posted Q1 2026 revenue of PLN 726.7 m (+80% YoY vs PLN 402.9 m) and EBITDA of PLN 56.4 m (+28%). Investment-gold sales: 838 kg (+38% by weight YoY). 2025 closed with EBITDA of around PLN 160 m (+29%) and net profit of around PLN 500 m (a significant part from the developer segment). Bulwary Praskie: 747 apartments with occupancy permits, 95% sold or reserved. Recommended dividend: PLN 1.5 per share (PLN 76.5 m).
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
